TABLE 1.
Participant characteristics | |||
---|---|---|---|
Infliximab (n = 9) | Placebo (n = 8) | p‐value | |
Age, years (mean, SD) | 47.6 (10.3) | 45.9(10.7) | .56 |
Sex, (n, female, %) | 8 (88.9) | 7 (87.5) | .73 |
Caucasian race (n, %) | 2 (22.2) | 3 (37.5) | .49 |
Baseline total score MADRS (mean, SD) CGIS (mean, SD) |
32.7(7.6) | 28.5(4.24) | .54 |
4.22(.67) | 4.4 (0.5) | .72 |